Image may be NSFW.
Clik here to view.
Alfred E. Mann, a pioneer in the biopharmaceutical industry and founder of MannKind Corp., has died at the age of 90.
Mann had recently resigned as chairman of Valencia-based MannKind(Nasdaq: MNKD), the maker of the inhaled insulin drug Afrezza. Mann, who had been chairman since 2001, was replaced with board member and former chairman and CEO of Northrop Grumman Corp., Kent Kresa. From November 2003 until January this year, Mann also was MannKind’s CEO until Matthew Pfeffer was named his successor.
Mann…
Clik here to view.
Alfred E. Mann, a pioneer in the biopharmaceutical industry and founder of MannKind Corp., has died at the age of 90.
Mann had recently resigned as chairman of Valencia-based MannKind(Nasdaq: MNKD), the maker of the inhaled insulin drug Afrezza. Mann, who had been chairman since 2001, was replaced with board member and former chairman and CEO of Northrop Grumman Corp., Kent Kresa. From November 2003 until January this year, Mann also was MannKind’s CEO until Matthew Pfeffer was named his successor.
Mann…
